What's new? Log in Free sign up

Metsera (MTSR)

Company Profile

Company profile

Ticker

MTSR

Exchange

Website

CEO

Christopher Whitten Bernard

Incorporated

Location

Fiscal year end

Sector

Health Technology > Biotechnology

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • AbbVie • Teva Pharmaceutical Industries Limited • Bausch Health Companies • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris ...

SEC CIK

Corporate docs

Underwriting Agreements

MTSR stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Leerink Partners

Latest filings (excl ownership)

View all

Securities registration termination

Registration of securities for employees (post-effective amendment)

Completion of Acquisition or Disposition of Assets

Exchange delisting

Quarterly report

12 Nov 25

Additional proxy soliciting materials

Pfizer and Metsera Enter into Merger Agreement Amendment

Metsera Issues Statement in Response to Litigation Ruling

Additional proxy soliciting materials

Metsera Receives Amended Proposal from Novo Nordisk

Latest ownership filings

View all

Beneficial ownership report (amended)

Change in insider ownership

Beneficial ownership report (amended)

Beneficial ownership report

Change in insider ownership

Financial summary

Financial statements Chart MTSR financial data

Quarter (USD)	Sep 25	Jun 25	Mar 25	Dec 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	448.50 mm	448.50 mm	448.50 mm	448.50 mm	448.50 mm	448.50 mm
Cash burn (monthly)	27.47 mm	(no burn)	40.69 mm	28.13 mm	(no burn)	(no burn)
Cash used (since last report)	66.37 mm	n/a	98.33 mm	67.96 mm	n/a	n/a
Cash remaining	382.13 mm	n/a	350.17 mm	380.54 mm	n/a	n/a
Runway (months of cash)	13.9	n/a	8.6	13.5	n/a	n/a

Beta Read what these cash burn values mean

Financial data from Metsera earnings reports.

Institutional ownership, Q4 2024

MTSR institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	0	0
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0.00	0.00
Total shares	0.00	0.00
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MTSR insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
13 Nov 25	Joshua Pinto	Common Stock	Sale back to company	Dispose D	No	No	0	2,688	0.00	0
13 Nov 25	Joshua Pinto	Common Stock	Sale back to company	Dispose D	Yes	No	4.33	148,953	644.97 k	0
13 Nov 25	Joshua Pinto	Common Stock	Sale back to company	Dispose D	No	No	29.25	16,125	471.66 k	0
13 Nov 25	Joshua Pinto	RSU Common Stock	Grant	Acquire A	No	No	0	2,688	0.00	2,688
13 Nov 25	Stonehouse Jon P	Common Stock	Sale back to company	Dispose D	No	No	0	2,688	0.00	0
13 Nov 25	Stonehouse Jon P	Common Stock	Sale back to company	Dispose D	No	No	19.81	47,730	945.53 k	0
13 Nov 25	Stonehouse Jon P	RSU Common Stock	Grant	Acquire A	No	No	0	2,688	0.00	2,688
13 Nov 25	Brian Hubbard	Common Stock	Sale back to company	Dispose D	No	No	0	17,000	0.00	0
13 Nov 25	Brian Hubbard	Common Stock	Sale back to company	Dispose D	No	No	8.18	106,395	870.31 k	0
13 Nov 25	Brian Hubbard	Common Stock	Sale back to company	Dispose D	No	No	29.25	120,000	3.51 mm	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

'Pfizer Kicks Off US Dollar Bond Sale to Help Fund Metsera Deal' - Bloomberg

https://www.bloomberg.com/news/articles/2025-11-18/pfizer-kicks-off-us-dollar-bond-sale-to-help-fund-metsera-deal

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market

Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com and TuneIn.

Ozempic Maker Novo Nordisk Faces Board Shakeup

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Pfizer Completes Acquisition Of All Outstanding Common Shares Of Metsera For $65.60 Per Share In Cash

Press releases

From Benzinga Pro

Pfizer Completes Acquisition of Metsera

Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape Complements and transforms Pfizer's Internal Medicine portfolio Positions Pfizer to

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

Revised transaction values Metsera at up to $86.25 per shareMetsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger agreement and approve the

Metsera Issues Statement in Response to Litigation Ruling

NEW YORK, Nov. 5, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ:MTSR) ("Metsera" or the "Company") today issued the following statement in response to a ruling in the litigation filed against the Company by

Halper Sadeh LLC Encourages TGNA, MTSR, CYBR Shareholders to Contact the Firm to Discuss Their Rights

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote- CYBR, TGNA, MTSR, and GES

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.